サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1760731

トランスクリプトミクスの世界市場レポート 2025

Transcriptomics Global Market Report 2025

出版日
ページ情報
英文 175 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
トランスクリプトミクスの世界市場レポート 2025
出版日: 2025年07月01日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

トランスクリプトミクス市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.1％で96億5,000万米ドルに成長します。予測期間中に予想される成長は、単一細胞リボ核酸シーケンスの採用の増加、空間トランスクリプトミクスの統合の増加、マルチオミクスアプローチの需要の増加、疾患の早期発見への注目の高まり、非コードリボ核酸の重要性に対する認識の高まりによってもたらされます。予測期間の主な動向としては、次世代シーケンシング（NGS）技術の進歩、空間的トランスクリプトミクスの革新、バイオインフォマティクスツールの改善、トランスクリプトミクスにおける機械学習の統合、リアルタイム・トランスクリプトーム解析技術の進歩などが挙げられます。

個別化医療の採用拡大が、今後のトランスクリプトミクス市場の成長を牽引すると予想されます。個別化医療には、個人の遺伝的体質、ライフスタイル、環境要因に基づいて治療をカスタマイズすることが含まれます。このアプローチは、遺伝子配列決定の進歩により、その人の遺伝子プロファイルに合わせた治療が可能になり、より高い効果が得られるようになったため、支持を集めています。トランスクリプトミクスは、ユニークな遺伝子発現パターンを明らかにすることで、より効果的で副作用を減らし、病気の早期診断をサポートする個別化治療を可能にします。例えば、2024年2月、個別化医療連合（Personalized Medicine Coalition）は、FDAが2023年に希少疾患に対する新たな個別化治療を16件承認したことを報告しました。その結果、個別化医療の普及がトランスクリプトミクス市場の成長に寄与しています。

トランスクリプトミクス市場の各社は、細胞機能や疾患メカニズムに関するより深い知見を得るために、シングルセル・スパシャル・パネルなどの革新的な製品の開発に注力しています。単一細胞空間パネルは、組織内の細胞の位置を保持しながら、個々の細胞レベルで遺伝子発現を解析します。これらのパネルは、シングルセルトランスクリプトミクスと空間データを組み合わせ、細胞活動と組織構造の両方に関する洞察を提供します。例えば、2024年2月、NanoString Technologies社は、CosMx 6,000 plex RNA Assayを発売しました。これは、ほぼすべてのヒト生物学的経路にわたって6,000以上のRNAターゲットを測定できる、初の商業的シングルセル空間パネルです。CosMx Spatial Molecular Imager（SMI）用に設計されたこの画期的な製品により、研究者は高精度と高度な細胞セグメンテーションにより、単一細胞および細胞内分解能で遺伝子のプロファイリングを行うことができます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界トランスクリプトミクス PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界のトランスクリプトミクス市場：成長率分析
  • 世界のトランスクリプトミクス市場の実績：規模と成長, 2019-2024
  • 世界のトランスクリプトミクス市場の予測：規模と成長, 2024-2029, 2034F
  • 世界トランスクリプトミクス総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界のトランスクリプトミクス市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 機器
  • 消耗品
  • ソフトウェア
  • サービス
  • 世界のトランスクリプトミクス市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • マイクロアレイ
  • リアルタイム定量ポリメラーゼ連鎖反応
  • シーケンシング技術
  • 世界のトランスクリプトミクス市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断と疾患プロファイリング
  • 創薬
  • その他の用途
  • 世界のトランスクリプトミクス市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 学術研究機関
  • 製薬会社
  • バイオテクノロジー企業
  • その他のエンドユーザー
  • 世界のトランスクリプトミクス市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • マイクロアレイ機器
  • シーケンシング機器
  • ポリメラーゼ連鎖反応（PCR）装置
  • その他のトランスクリプトミクス楽器
  • 世界のトランスクリプトミクス市場消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 試薬
  • プローブ
  • キット
  • チップス
  • 世界のトランスクリプトミクス市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • データ分析ソフトウェア
  • データ管理ソフトウェア
  • 可視化ソフトウェア
  • バイオインフォマティクスソフトウェア
  • 世界のトランスクリプトミクス市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • データ分析サービス
  • サンプル調製サービス
  • シーケンシングサービス
  • コンサルティングサービス

第7章 地域別・国別分析

  • 世界のトランスクリプトミクス市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のトランスクリプトミクス市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • トランスクリプトミクス市場：競合情勢
  • トランスクリプトミクス市場：企業プロファイル
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Bio-Rad Laboratories Inc.
  • QIAGEN N.V.
  • Takara Bio Inc.
  • 10x Genomics Inc.
  • Oxford Nanopore Technologies plc
  • Genewiz Inc.
  • Pacific Biosciences of California Inc.
  • NanoString Technologies Inc.
  • Singleron Biotechnologies
  • SCIEX
  • CD Genomics Inc.
  • Parse Biosciences Inc.
  • Lexogen GmbH
  • LC Sciences LLC
  • Arraystar Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • トランスクリプトミクス市場2029：新たな機会を提供する国
  • トランスクリプトミクス市場2029：新たな機会を提供するセグメント
  • トランスクリプトミクス市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r35608

Transcriptomics is the study of all ribonucleic acid (RNA) transcripts generated by the genome within a specific cell, tissue, or condition. It aids in deciphering gene expression patterns and regulatory processes, revealing how they change in response to diseases or environmental influences. This field provides valuable insights into cellular functions and disease mechanisms. Transcriptomics plays a key role in biomarker discovery, identifying therapeutic targets, and advancing personalized medicine.

The primary categories of transcriptomics include instruments, consumables, software, and services. Instruments are vital in transcriptomics as they allow for the precise analysis of gene expression through high-throughput sequencing, amplification, and RNA detection. Various technologies are employed, such as microarrays, real-time quantitative polymerase chain reaction, and sequencing technologies. These tools are used for multiple applications, including diagnostics, disease profiling, drug discovery, and others, and are utilized by a wide range of end-users, such as academic and research institutions, pharmaceutical companies, biotechnology firms, and more.

The transcriptomics market research report is one of a series of new reports from The Business Research Company that provides transcriptomics market statistics, including the transcriptomics industry global market size, regional shares, competitors with the transcriptomics market share, detailed transcriptomics market segments, market trends, and opportunities, and any further data you may need to thrive in the transcriptomics industry. This transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transcriptomics market size has grown strongly in recent years. It will grow from $6.51 billion in 2024 to $7.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the past can be attributed to an increasing emphasis on personalized medicine, a rising prevalence of cancer, the incorporation of genomics in clinical diagnostics, the expansion of ribonucleic acid sequencing, and a growing demand for biomarker discovery.

The transcriptomics market size is expected to see strong growth in the next few years. It will grow to $9.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The expected growth in the forecast period is driven by the rising adoption of single-cell ribonucleic acid sequencing, the increasing integration of spatial transcriptomics, the growing demand for multiomics approaches, a heightened focus on early disease detection, and greater awareness of the significance of non-coding ribonucleic acids. Key trends for the forecast period include advancements in next-generation sequencing (NGS) technologies, innovations in spatial transcriptomics, improvements in bioinformatics tools, the integration of machine learning in transcriptomics, and progress in real-time transcriptomic analysis technologies.

The growing adoption of personalized medicine is expected to drive the growth of the transcriptomics market in the future. Personalized medicine involves customizing treatments based on an individual's genetic makeup, lifestyle, and environmental factors. This approach is gaining traction due to advancements in genetic sequencing, which allow for treatments tailored to a person's genetic profile for greater effectiveness. Transcriptomics helps uncover unique gene expression patterns, enabling personalized treatments that are more effective, reduce side effects, and support early disease diagnosis. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, compared to just six in 2022. As a result, the increasing adoption of personalized medicine is contributing to the growth of the transcriptomics market.

Companies in the transcriptomics market are focused on developing innovative products such as single-cell spatial panels to gain deeper insights into cellular functions and disease mechanisms. Single-cell spatial panels analyze gene expression at the individual cell level while preserving the cells' positions within the tissue. These panels combine single-cell transcriptomics with spatial data, providing insights into both cellular activity and tissue structure. For instance, in February 2024, NanoString Technologies launched the CosMx 6,000 plex RNA Assay, the first commercial single-cell spatial panel capable of measuring over 6,000 RNA targets across nearly all human biological pathways. This breakthrough, designed for use with the CosMx Spatial Molecular Imager (SMI), enables researchers to profile genes at single-cell and subcellular resolution with high accuracy and advanced cell segmentation.

In July 2024, Illumina, Inc., a U.S.-based provider of DNA sequencing and array-based technologies, acquired Fluent BioSciences for an undisclosed amount. This acquisition aims to enhance Illumina's multiomics capabilities by integrating Fluent's innovative, scalable single-cell technology, which eliminates the need for complex and expensive equipment. This enables faster, more cost-effective, and comprehensive discoveries in genomics and cell biology. Fluent BioSciences specializes in single-cell analysis technology, a key method in transcriptomics that allows researchers to profile gene expression at the individual cell level.

Major players in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, and Arraystar Inc.

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transcriptomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transcriptomics market consists of revenues earned by entities by providing services such as voice gene expression analysis, ribonucleic acid sequencing, bioinformatics solutions, and data interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The transcriptomics market also includes sales of RNA extraction kits, library preparation kits, and cDNA synthesis kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Instruments; Consumables; Software; Services
  • 2) By Technology: Micro Array; Real-Time Quantitative Polymerase Chain Reaction; Sequencing Technologies
  • 3) By Application: Diagnostics And Disease Profiling; Drug Discovery; Other Applications
  • 4) By End-User: Academic And Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Instruments: Microarray Instruments; Sequencing Instruments; Polymerase Chain Reaction (PCR) Instruments; Other Transcriptomics Instruments
  • 2) By Consumables: Reagents; Probes; Kits; Chips
  • 3) By Software: Data Analysis Software: Data Management Software; Visualization Software: Bioinformatics Software
  • 4) By Services: Data Analysis Services; Sample Preparation Services; Sequencing Services; Consulting Services
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Becton Dickinson and Company; Agilent Technologies Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transcriptomics Market Characteristics

3. Transcriptomics Market Trends And Strategies

4. Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transcriptomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Transcriptomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Transcriptomics Market Growth Rate Analysis
  • 5.4. Global Transcriptomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Transcriptomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Transcriptomics Total Addressable Market (TAM)

6. Transcriptomics Market Segmentation

  • 6.1. Global Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Consumables
  • Software
  • Services
  • 6.2. Global Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Micro Array
  • Real-Time Quantitative Polymerase Chain Reaction
  • Sequencing Technologies
  • 6.3. Global Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics And Disease Profiling
  • Drug Discovery
  • Other Applications
  • 6.4. Global Transcriptomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic And Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Other End-Users
  • 6.5. Global Transcriptomics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Microarray Instruments
  • Sequencing Instruments
  • Polymerase Chain Reaction (PCR) Instruments
  • Other Transcriptomics Instruments
  • 6.6. Global Transcriptomics Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents
  • Probes
  • Kits
  • Chips
  • 6.7. Global Transcriptomics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Data Management Software
  • Visualization Software
  • Bioinformatics Software
  • 6.8. Global Transcriptomics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Services
  • Sample Preparation Services
  • Sequencing Services
  • Consulting Services

7. Transcriptomics Market Regional And Country Analysis

  • 7.1. Global Transcriptomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Transcriptomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Transcriptomics Market

  • 8.1. Asia-Pacific Transcriptomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Transcriptomics Market

  • 9.1. China Transcriptomics Market Overview
  • 9.2. China Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Transcriptomics Market

  • 10.1. India Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Transcriptomics Market

  • 11.1. Japan Transcriptomics Market Overview
  • 11.2. Japan Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Transcriptomics Market

  • 12.1. Australia Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Transcriptomics Market

  • 13.1. Indonesia Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Transcriptomics Market

  • 14.1. South Korea Transcriptomics Market Overview
  • 14.2. South Korea Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Transcriptomics Market

  • 15.1. Western Europe Transcriptomics Market Overview
  • 15.2. Western Europe Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Transcriptomics Market

  • 16.1. UK Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Transcriptomics Market

  • 17.1. Germany Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Transcriptomics Market

  • 18.1. France Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Transcriptomics Market

  • 19.1. Italy Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Transcriptomics Market

  • 20.1. Spain Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Transcriptomics Market

  • 21.1. Eastern Europe Transcriptomics Market Overview
  • 21.2. Eastern Europe Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Transcriptomics Market

  • 22.1. Russia Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Transcriptomics Market

  • 23.1. North America Transcriptomics Market Overview
  • 23.2. North America Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Transcriptomics Market

  • 24.1. USA Transcriptomics Market Overview
  • 24.2. USA Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Transcriptomics Market

  • 25.1. Canada Transcriptomics Market Overview
  • 25.2. Canada Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Transcriptomics Market

  • 26.1. South America Transcriptomics Market Overview
  • 26.2. South America Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Transcriptomics Market

  • 27.1. Brazil Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Transcriptomics Market

  • 28.1. Middle East Transcriptomics Market Overview
  • 28.2. Middle East Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Transcriptomics Market

  • 29.1. Africa Transcriptomics Market Overview
  • 29.2. Africa Transcriptomics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Transcriptomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Transcriptomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Transcriptomics Market Competitive Landscape And Company Profiles

  • 30.1. Transcriptomics Market Competitive Landscape
  • 30.2. Transcriptomics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Transcriptomics Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Takara Bio Inc.
  • 31.4. 10x Genomics Inc.
  • 31.5. Oxford Nanopore Technologies plc
  • 31.6. Genewiz Inc.
  • 31.7. Pacific Biosciences of California Inc.
  • 31.8. NanoString Technologies Inc.
  • 31.9. Singleron Biotechnologies
  • 31.10. SCIEX
  • 31.11. CD Genomics Inc.
  • 31.12. Parse Biosciences Inc.
  • 31.13. Lexogen GmbH
  • 31.14. LC Sciences LLC
  • 31.15. Arraystar Inc.

32. Global Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transcriptomics Market

34. Recent Developments In The Transcriptomics Market

35. Transcriptomics Market High Potential Countries, Segments and Strategies

  • 35.1 Transcriptomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Transcriptomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Transcriptomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer